Yahoo! Finance: VRUS NewsLatest Financial News for PHARMASSET INC.PHARMASSET INC Financials (EDGAR Online Financials)- August 22, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=vrus Telaprevir Tests Its Luck (at Motley Fool)- August 20, 2008http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12lnt6ji4/*http://www.fool.com/inves... New Star Analyst Rankings for PHARMASSET INC. (StarMine)- August 16, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/v/vrus.html Biotech-Stock Mailbag: Genentech (at TheStreet.com)- August 15, 2008http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1246ul0jj/*http://www.thestreet.com/... PHARMASSET INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)- August 14, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/080814/vrus8-k.html PHARMASSET INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)- August 14, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/080814/vrus10-q.html Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 (PR Newswire)- August 14, 2008 Pharmasset, Inc. , a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported unaudited financial results for the third fiscal quarter ended June 30, 2008.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080814/clth087.... PHARMASSET INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)- August 13, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/080813/vrus8-k.html Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th (PR Newswire)- August 8, 2008 Pharmasset, Inc. management will present at the 28th Annual Canaccord Adams Global Growth Conference being held from August 12 - 14, 2008 at the Intercontinental Hotel in Boston, MA.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080808/clf056.h... Pharmasset drug passes early-stage goal (AP)- August 5, 2008 Pharmasset Inc. said Tuesday its hepatitis C treatment candidate met safety goals in part of an early-stage study. The drug candidate, called R7128, was administered to patients over a four-week period in 1,000-milligram doses.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080805/pharmasset_s... |